MCA logo
MCA logo

PUBLIC PORTAL

MEDICALLY REVIEWED

Gadopiclenol (Elucirem™) for Contrast-Enhanced MRI

MRI
The US FDA granted regulatory approval to Gadopiclenol (Elucirem™), a new macrocyclic GBCA for use in adults and children aged 2 years and older, for contrast-enhanced MRI.

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: